|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 22.20 HKD | -5.45% |
|
-5.69% | -27.17% |
| 08:22pm | Certain H Shares of Medtide Inc. are subject to a Lock-Up Agreement Ending on 30-JUN-2026. | CI |
| 06-18 | Medtide Inc. Announces Abolishment of the Supervisory Committee | CI |
Projected Income Statement: Medtide Inc.
| Fiscal Period: December | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| Net sales 1 | 570.1 | 684.1 | 875.7 | 1,068 |
| Change | - | 20% | 28% | 22% |
| EBITDA 1 | 240.2 | 284.6 | 377.7 | 452.1 |
| Change | - | 18.45% | 32.74% | 19.7% |
| EBIT 1 | 212.4 | 249.7 | 328.4 | 408.1 |
| Change | - | 17.56% | 31.51% | 24.28% |
| Interest Paid | - | - | - | - |
| Earnings before Tax (EBT) | - | - | - | - |
| Change | - | - | - | - |
| Net income | - | - | - | - |
| Change | - | - | - | - |
| Announcement Date | 3/30/26 | - | - | - |
1CNY in Million
Estimates
Forecast Balance Sheet: Medtide Inc.
| Fiscal Period: December | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| Net Debt 1 | -857 | -898 | -1,081 | -1,263 |
| Change | - | -4.76% | -20.38% | -16.84% |
| Announcement Date | 3/30/26 | - | - | - |
1CNY in Million
Estimates
Cash Flow Forecast: Medtide Inc.
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| CAPEX 1 | 40.13 | 92.15 | 55.18 | 21.02 | 128.4 |
| Change | - | 129.63% | -40.12% | -61.9% | 510.89% |
| Free Cash Flow (FCF) 1 | - | 14.41 | 8.273 | -3.381 | 69.14 |
| Change | - | - | -42.61% | -140.87% | 2,144.94% |
| Announcement Date | 12/6/24 | 12/6/24 | 12/6/24 | 6/20/25 | 4/23/26 |
1CNY in Million
Estimates
Forecast Financial Ratios: Medtide Inc.
| Fiscal Period: December | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
Profitability | ||||
| EBITDA Margin (%) | 42.14% | 41.59% | 43.13% | 42.32% |
| EBIT Margin (%) | 37.26% | 36.5% | 37.5% | 38.2% |
| EBT Margin (%) | - | - | - | - |
| Net margin (%) | - | - | - | - |
| FCF margin (%) | - | - | - | - |
| FCF / Net Income (%) | - | - | - | - |
Profitability | ||||
| ROA | - | - | - | - |
| ROE | 23.3% | 14.25% | 15.57% | 16.32% |
Financial Health | ||||
| Leverage (Debt/EBITDA) | - | - | - | - |
| Debt / Free cash flow | - | - | - | - |
Capital Intensity | ||||
| CAPEX / Current Assets (%) | - | - | - | - |
| CAPEX / EBITDA (%) | - | - | - | - |
| CAPEX / FCF (%) | - | - | - | - |
Items per share | ||||
| Cash flow per share 1 | - | - | - | - |
| Change | - | - | - | - |
| Dividend per Share 1 | - | - | - | - |
| Change | - | - | - | - |
| Book Value Per Share 1 | 11.87 | 13.69 | 16 | 18.84 |
| Change | - | 15.34% | 16.87% | 17.75% |
| EPS 1 | - | - | - | - |
| Change | - | - | - | - |
| Nbr of stocks (in thousands) | 141,800 | 141,800 | 141,800 | 141,800 |
| Announcement Date | 3/30/26 | - | - | - |
1CNY
Estimates
| 2026 * | 2027 * | |
|---|---|---|
| P/E | - | - |
| PBR | 1.49x | 1.27x |
| EV / Sales | 2.91x | 2.06x |
| Yield | - | - |
EPS & Dividend
Y-o-Y evolution of P/E
Year-on-year evolution of the Yield
Sell
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
20.35CNY
Average target price
25.19CNY
Spread / Average Target
+23.78%
Net sales - Rate of surprise
- Stock Market
- Stocks
- 3880 Stock
- Financials Medtide Inc.
Select your edition
All financial news and data tailored to specific country editions
